Oncolys BioPharma Inc. is a Tokyo-based bioventure established in Japan in March 2004. Its mission is to contribute to the advancement of medical science in the world through bringing innovation to the existing treatments for cancer and serious infectious diseases, using its virology-based new drug discovery technologies.
The company operates in two business segments. Pharmaceutical Business segment is engaged in the research, development, manufacture and marketing of novel drugs. Its major pipeline Telomelysin (OBP-301), an oncolytic adenovirus immunotherapy is in clinical development targeting various types of solid tumors including melanoma , HCC and esophageal cancer. Along with Telomelysin, an anti-HIV drug OBP-601 (Censavudine) and a novel HDAC inhibitor OBP-801 are also under development in the United States. Diagnostics Business segment is engaged in the research, development, manufacture and marketing of CTC (Circulating Tumor Cell) detection adenovirus TelomeScan, as well as the provision of inspection services.
Oncolys was listed on the Tokyo Stock Exchange Mothers Market in December 2014 and has a clinical laboratory center in Kobe, Japan and a subsidiary in New Jersey, USA.
Company Details
- Employees
- 26
- Founded
- -
- Address
- 4-1-28, Minato-Ku,tokyo 105-0001,japan
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- oncolys.com
- HQ
- Minato-ku, Tokyo
Oncolys Biopharma Inc. Questions
Oncolys Biopharma Inc.'s website is oncolys.com
Oncolys Biopharma Inc.'s LinkedIn profile is https://www.linkedin.com/company/oncolys-biopharma-inc-
Oncolys Biopharma Inc. has
26 employees.
View email and phone details for 26
employees at Oncolys Biopharma Inc..
Oncolys Biopharma Inc.'s industry is
Biotechnology Research
Oncolys Biopharma Inc.'s top competitors are
Morunda | Pharmaceutical | Medical Device Recruiting | Japan (Jpac) Asia (Apac),
Novocure,
Optieum Biotechnologies Inc.,
Rohto Pharmaceutical Co., Ltd.,
Idera Pharmaceuticals,
オンコリスバイオファーマ（株）,
Arcalis, Inc.,
Ricoh Biosciences,
Nxera Pharma,
Centurion İlaç.
Oncolys Biopharma Inc.'s categories are Biotechnology Research
Oncolys Biopharma Inc.'s founding year is 2004
